自動調合機器の世界市場：洞察、競合情勢、市場予測：2028年

世界の自動調合機器の市場規模は、2023年から2028年の予測期間中に6.8%のCAGRで拡大すると予測されています。自動調合機器の需要は、世界の疾病負担の増加や処方薬の使用の増加、化学療法や個別化された投薬に対する需要の増加、投薬ミスを最小限に抑えるニーズの高まり、製品の発売や承認の増加、主要企業による研究開発活動の急増などによって後押しされており、それによって2023年から2028年までの予測期間中に自動調合機器市場の全体的な成長に寄与しています。

自動配合装置市場は、さまざまな要因によって製品需要が伸びていますが、主要な要因の1つは慢性疾患の有病率の上昇です。慢性疾患は欧州における死亡の主な原因であり、全疾患負担の77%、全死亡の86%を占めています。また、世界中で合計1929万2,789件の新規がん症例が報告されています。同データによると、2020年における全世界のあらゆる種類のがんの5年間の有病率は5,055万287人です。

世界中で慢性疾患の負担が増加しているため、有病率の増加は様々な医薬品の需要を増加させ、最終的に配合機器の需要を増加させる。自動調合機器は、ロボットやコンピュータ制御の調剤、正確な投薬、ミスの可能性の低下など、最先端の技術を採用しています。

当レポートでは、世界の自動調合機器市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 自動調合機器市場レポートのイントロダクション

第2章 自動調合機器市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 自動調合機器市場の主要な要因分析

• 自動調合機器市場の促進要因
• 自動調合機器市場の抑制要因と課題
• 自動調合機器市場の機会

第5章 自動調合機器市場におけるポーターのファイブフォース分析

第6章 自動調合機器の市場概要

• 製品タイプ別
• エンドユーザー別
• 地域別

第7章 自動調合機器市場における企業と製品プロファイル

• Baxter
• B.Braun SE
• COMECER S.p.A.
• EQUASHIELD
• icumedical
• Grifols, S.A.
• Omnicell, Inc.
• BD
• ARxUM
• NewIcon
• Loccioni
• Fagron

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Automated Compounding Devices Market in Global (2020-2028)
• Table 3: Automated Compounding Devices Market in Global by Product Type (2020-2028)
• Table 4: Automated Compounding Devices Market in Global by End-User (2020-2028)
• Table 5: Automated Compounding Devices Market in Global by Geography (2020-2028)
• Table 6: Automated Compounding Devices Market in North America (2020-2028)
• Table 7: Automated Compounding Devices Market in the US (2020-2028)
• Table 8: Automated Compounding Devices Market in Canada (2020-2028)
• Table 9: Automated Compounding Devices Market in Mexico (2020-2028)
• Table 10: Automated Compounding Devices Market in Europe (2020-2028)
• Table 11: Automated Compounding Devices Market in France (2020-2028)
• Table 12: Automated Compounding Devices Market in Germany (2020-2028)
• Table 13: Automated Compounding Devices Market in the United Kingdom (2020-2028)
• Table 14: Automated Compounding Devices Market in Italy (2020-2028)
• Table 15: Automated Compounding Devices Market in Spain (2020-2028)
• Table 16: Automated Compounding Devices Market in the Rest of Europe (2020-2028)
• Table 17: Automated Compounding Devices Market in Asia-Pacific (2020-2028)
• Table 18: Automated Compounding Devices Market in China (2020-2028)
• Table 19: Automated Compounding Devices Market in Japan (2020-2028)
• Table 20: Automated Compounding Devices Market in India (2020-2028)
• Table 21: Automated Compounding Devices Market in Australia (2020-2028)
• Table 22: Automated Compounding Devices Market in South Korea (2020-2028)
• Table 23: Automated Compounding Devices Market in Rest of Asia-Pacific (2020-2028)
• Table 24: Automated Compounding Devices Market in the Rest of the World (2020-2028)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Automated Compounding Devices Market in Global (2020-2028)
• Figure 3: Automated Compounding Devices Market in Global by Product Type (2020-2028)
• Figure 4: Automated Compounding Devices Market in Global by End-User (2020-2028)
• Figure 5: Automated Compounding Devices Market in Global by Geography (2020-2028)
• Figure 6: Automated Compounding Devices Market in North America (2020-2028)
• Figure 7: Automated Compounding Devices Market in the US (2020-2028)
• Figure 8: Automated Compounding Devices Market in Canada (2020-2028)
• Figure 9: Automated Compounding Devices Market in Mexico (2020-2028)
• Figure 10: Automated Compounding Devices Market in Europe (2020-2028)
• Figure 11: Automated Compounding Devices Market in France (2020-2028)
• Figure 12: Automated Compounding Devices Market in Germany (2020-2028)
• Figure 13: Automated Compounding Devices Market in the United Kingdom (2020-2028)
• Figure 14: Automated Compounding Devices Market in Italy (2020-2028)
• Figure 15: Automated Compounding Devices Market in Spain (2020-2028)
• Figure 16: Automated Compounding Devices Market in the Rest of Europe (2020-2028)
• Figure 17: Automated Compounding Devices Market in Asia-Pacific (2020-2028)
• Figure 18: Automated Compounding Devices Market in China (2020-2028)
• Figure 19: Automated Compounding Devices Market in Japan (2020-2028)
• Figure 20: Automated Compounding Devices Market in India (2020-2028)
• Figure 21: Automated Compounding Devices Market in Australia (2020-2028)
• Figure 22: Automated Compounding Devices Market in South Korea (2020-2028)
• Figure 23: Automated Compounding Devices Market in Rest of Asia-Pacific (2020-2028)
• Figure 24: Automated Compounding Devices Market in the Rest of the World (2020-2028)
• Figure 25: Market Drivers
• Figure 26: Market Barriers
• Figure 27: Marker Opportunities
• Figure 28: PORTER'S Five Force Analysis

Automated Compounding Devices Market By Product Type (Gravimetric Automated Compounding Systems And Volumetric Automated Compounding Systems), End-User (Hospitals, Specialty Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the growing adoption of chemotherapy and personalized medication and the rising need to minimize medication errors across the globe.

The global automated compounding devices market is estimated to grow at a CAGR of 6.8% during the forecast period from 2023 to 2028. The demand for automated compounding devices is being boosted by the rising global disease burden and the increasing use of prescription medications, the growing demand for chemotherapy and personalized medication and the rising need to minimize medication errors, rising product launches and approvals, and surging research and developmental activities by the key players, among others are thereby contributing to the overall growth of the automated compounding devices market during the forecast period from 2023-2028.

Automated Compounding Devices Market Dynamics:

The automated compounding devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the rising prevalence of chronic disorders.

For instance, according to the European Chronic Disease Alliance, chronic diseases are the leading cause of mortality in Europe, representing 77% of the total disease burden and 86% of all deaths.

The data published by GLOBOCAN in the year 2020 stated that a total of 19,292,789 new cases of cancer were reported worldwide. As per the same data, the five-year prevalence for all types of cancer across the globe is 50,550,287, in 2020.

As per the above-mentioned source, the cancer incidence in Asia rose to 169.1 per 100,000 inhabitants, accounting for 49.3% of the global cancer incidence. The most common cancers were lung (13.8%), breast (10.8%), and colorectal (10.6%) cancers.

Further, the International Diabetes Federation Atlas stated that the global diabetes prevalence in 2021 was estimated to be 537 million adults (20-79 years), rising to 643 million by 2030 and 783 million by 2045.

The increasing burden of chronic diseases across the globe will increase the demand for automated compounding devices as the increasing prevalence will increase the demand for various medicines, ultimately increasing the demand for compounding devices. Automated compounding devices employ cutting-edge technology, including robots and computer-controlled dispensing, precise dosing, and a lower possibility of mistakes.

Further, many government agencies are attempting to prevent medication errors and are building strategies and procedures to deal with them so that patients receive the right medications. For instance, the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) promotes open dialogue, improved reporting, and campaigns of medication error prevention techniques to increase the safe use of medications and increase public awareness of medication errors. According to the latest data provided by The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) data, almost 0.1 million individuals each year pass away as a result of medical mistakes that happen in hospitals. Additionally, drug errors cause more deaths each year than job accidents. Thus, to minimize medication and compounding errors, governments in several regions are encouraging the use of automated compounding and medication tools in pharmacies and hospitals. Thus, this is considered to be a significant factor propelling the growth of the automated compounding systems market.

Therefore, the above-mentioned factors are contributing to the growth of the automated compounding devices market during the forecast period from 2023-2028.

However, high cost of the device and the complex installation of the device, robotic automated compounding systems are limited in the size of vials, acting as a barrier for the market, and others may restrict the automated compounding devices market growth.

Automated Compounding Devices Market Segment Analysis:

Automated Compounding Devices Market by Product Type (Gravimetric Automated Compounding Systems and Volumetric Automated Compounding Systems), End-User (Hospitals, Specialty Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World).

In the product type segment of the automated compounding devices market, the volumetric automated compounding systems category is expected to amass a significant revenue share in the year 2022. This can be attributed to the advantages and applications associated with volumetric automated compounding systems. Moreover, increasing demand for technologically advanced products and the rising product launches in the market will in turn lead to an increased demand for the segment.

For instance, volumetric automated compounding devices set are rated with a manufacturer-recommended volume that they can deliver before replacement is necessary.

Volumetric automated compounding devices determine the amount of solution transferred to the final container by the amount of rotor rotation, the tubing diameter, and the tubing length.

Volumetric systems can be affected by solution viscosity, tubing diameters, and length, the height at which a source ingredient or final container is hung, tube or distal restrictions, and room temperature.

Moreover, in December 2022, Baxter International Inc., a global leader in nutrition therapy, launched the ExactaMix Pro Automated Compounder, which is expected to be available to customers in the United States in early 2023. ExactaMix Pro is the first and only automated compounder certified by the U.S. Food and Drug Administration (FDA)-recognized UL 2900-2-1 cybersecurity standard.

Thus, the above-mentioned factors are likely to propel the demand for volumetric automated compounding systems, thereby contributing to the growth of the automated compounding devices market during the forecast period from 2023-2028.

North America is expected to dominate the overall Automated Compounding Devices Market:

Among all the regions, North America is estimated to account for the largest share of the Automated Compounding Devices market in the year 2022. This can be ascribed to the high prevalence of various chronic diseases, the increasing burden of the geriatric population, the highly developed healthcare system, and others that act as supportive factors in US market growth.

For instance, as per the Center for Disease Control and Prevention (CDC) latest study, it was estimated that nearly 6 in 10 adults in the US have a chronic disease. The increasing patient pool of chronic disease, will in turn increase the demand for various medicines especially personalized medicines, ultimately leading to an increase in the automated compounding devices which are used to dispense the medicines prepared to treat chronic diseases.

Moreover, government involvement in the compounding sector has encouraged market growth by reducing medication errors and pharmaceutical mistakes. Along with this, the surging R&D activities in the region are resulting in increased production of new drugs, which has resulted in a huge market need for automated compounding devices.

Further, the presence of various domicile players such as B.Braun, Baxter, and ARxIUM, among others will propel the market of automated compounding devices in the United States.

Thus, all the above-mentioned factors will lead to an increase in the North America automated compounding devices market growth during the forecasting period of 2023-2028.

Automated Compounding Devices Market Key Players:

Some of the key market players operating in the automated compounding devices market include Baxter, B.Braun SE, COMECER S.p.A., EQUASHIELD, Icumedical, Grifols, S.A., Omnicell, Inc., BD, ARxUM, NewIcon, Loccioni, Fagron, and others.

Recent Developmental Activities in the Automated Compounding Devices Market:

• In January 2018, an array of hospitals adopted Omnicell's IV compounding technology across North Carolina, to enhance safety, providing improved therapy, reduction in costs, and facilitating compliance in the IV room.

Key Takeaways from the Automated Compounding Devices Market Report Study:

• Market size analysis for current automated compounding devices market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global automated compounding devices market.
• Various opportunities available for the other competitor in the automated compounding devices market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028.
• Which are the top-performing regions and countries in the current automated compounding devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for automated compounding devices market growth in the coming future?

Target Audience who can be benefited from this Automated Compounding Devices Market Report Study:

• Automated compounding devices product providers
• Research organizations and consulting companies
• Automated compounding devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in automated compounding devices
• Various End-users who want to know more about the automated compounding devices market and the latest technological developments in the automated compounding devices market.

Frequently Asked Questions for the Automated Compounding Devices Market:

1. What are automated compounding devices?

• Automated compounding devices transfer one or more sterile component solutions to a sterile final container for patient preparation, thereby replacing or decreasing the need for drawing up component solutions with syringes, increasing the accuracy of the ingredient delivery, and reducing preparation time.

2. What is the market for global automated compounding devices?

• The global automated compounding devices market is estimated to grow at a CAGR of 6.8% during the forecast period from 2023 to 2028.

3. What are the drivers for the global automated compounding devices market?

• The demand for automated compounding devices is primarily being heightened by the growing adoption of chemotherapy and personalized medication, the rising need to minimize medication errors, the rising global disease burden, and the increasing use of prescription medications among others are thereby contributing to the overall growth of the automated compounding devices market during the forecast period from 2023-2028.

4. Who are the key players operating in the global automated compounding devices market?

• Some of the key market players operating in the automated compounding devices market include Baxter, B.Braun SE, COMECER S.p.A., EQUASHIELD, Icumedical, Grifols, S.A., Omnicell, Inc., BD, ARxUM, NewIcon, Loccioni, Fagron, and others.

5. Which region has the highest share in the automated compounding devices market?

• North America is expected to dominate the overall automated compounding devices market during the forecast period from 2023-2028. Factors such as the high prevalence of various chronic diseases, increasing burden of the geriatric population, highly developed healthcare system, and rising need to minimize medication errors among others will positively impact the North American automated compounding devices market.

Table of Contents

1. Automated Compounding Devices Market Report Introduction

2. Automated Compounding Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Automated Compounding Devices Market Key Factors Analysis

• 4.1. Automated Compounding Devices Market Drivers
  • 4.1.1. Increasing burden of chronic ailments across the globe
  • 4.1.2. Reducing the risk of contamination in pharmaceutical and cosmetic products
  • 4.1.3. Increased efficiency and accuracy of the finished pharmaceutical product
• 4.2. Automated Compounding Devices Market Restraints and Challenges
  • 4.2.1. High cost of the device and complex installation of the device
  • 4.2.2. Robotic automated compounding systems are limited in the size of vials, acting as a barrier to the market
• 4.3. Automated Compounding Devices Market Opportunities
  • 4.3.1. Growing use of automation in the healthcare industry
  • 4.3.2. Increasing demand for sterilized pharmaceutical products

5. Automated Compounding Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Automated Compounding Devices Market Layout

• 6.1. By Product Type
  • 6.1.1. Gravimetric Automated Compounding Systems
  • 6.1.2. Volumetric Automated Compounding Systems
• 6.2. By End-User
  • 6.2.1. Hospitals
  • 6.2.2. Specialty Centers
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.1.1. United States Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.1.2. Canada Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.1.3. Mexico Automated Compounding Devices Market Size in USD million (2020-2028)
  • 6.3.2. Europe Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.1. France Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.2. Germany Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.3. United Kingdom Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.4. Italy Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.5. Spain Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.2.6. Rest of Europe Automated Compounding Devices Market Size in USD million (2020-2028)
  • 6.3.3. Asia-Pacific Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.1. China Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.2. Japan Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.3. India Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.4. Australia Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.5. South Korea Automated Compounding Devices Market Size in USD million (2020-2028)
    • 6.3.3.6. Rest of the Asia-Pacific Automated Compounding Devices Market Size in USD million (2020-2028)
  • 6.3.4. Rest of the World (RoW) Automated Compounding Devices Market Size in USD million (2020-2028)

7. Automated Compounding Devices Market Company and Product Profiles

• 7.1. Baxter
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. B.Braun SE
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. COMECER S.p.A.
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. EQUASHIELD
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. icumedical
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Grifols, S.A.
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Omnicell, Inc.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. BD
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. ARxUM
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. NewIcon
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Loccioni
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Fagron
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us